See also this year's filing and all EDGAR filings for this company.
PDF Report 0001582249_2020_Actavia_LIFE_Sciences_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Assets" added to remainder. | industry.us_generic | {'missing_ratio': 0.7846008996756983, 'aggregate_val': 32944, 'exp_sum': 152944, 'exp_to_value': {'AssetsCurrent': 32630, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 314, 'remainder_Assets': 120000}} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Expenses', 'value': 5425824, 'size_variable': 'Assets', 'size_value': 32944, 'ratio': 164.7, 'threshold': 20} |
Graph
Absolute values for 0001582249, Actavia LIFE Sciences INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 71,579 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,722,985 |
| 2 | PropertyPlantAndEquipmentNet | 1,949 |
| 3 | remainder_Assets | 2,149,369 |
| 4 | LiabilitiesCurrent | 2,405,496 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 3,034 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 598,763 |
| 9 | ResearchAndDevelopmentExpense | 14,373 |
| 10 | remainder_Expenses | 294,450 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -28,794 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,945,882 |
| 1 | Liabilities | 2,408,530 |
| 2 | Expenses | 907,586 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 2,537,352 |
| 5 | NetIncome | -936,380 |
| 6 | ComprehensiveNetIncome | -936,380 |
| 7 | BaseVar | 4,145,396 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.25 |
| 9 | EconomicCapitalRatio | 2.49 |
Edgar->Model Mapping
Feature Distribution
Change over Time
